Siemens Healthineers Reports Fall in Profits, Citing Tariffs
By Aimee Look
Siemens Healthineers reported a fall in fourth-quarter profit after higher comparable revenue stemming from the transformation program of its diagnostics business was offset by a hit from U.S. tariffs.
The German healthcare company on Wednesday posted a net profit of 597 million euros ($685.5 million) for the three months through Sept. 30, down from 624 million euros in the same period last year.
It reported revenue of 6.32 billion euros for the quarter, down from 6.33 billion euros, but up 3.7% on a comparable basis.
Analysts had expected a net profit of 659 million euros and revenue of 6.45 billion euros, according to estimates compiled by Vara Research.
Adjusted earnings before interest and taxes fell 2% to 1.09 billion euros. The metric's margin declined to 17.4% from 17.7%.
"Higher tariffs had a negative effect in all segments," but revenue development and cost reductions from the company's diagnostics business plan were a buffer for the losses, it said.
Write to Aimee Look at aimee.look@wsj.com
(END) Dow Jones Newswires
November 05, 2025 01:42 ET (06:42 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
4 Stocks to Buy Before They Rise Further
2 Undervalued Stocks to Buy Before They Rebound
The 10 Best Companies to Invest in Now
The 10 Best Dividend Stocks
United States